Literature DB >> 30156149

Chinese Herbal Formulas and Renal Fibrosis: An Overview.

Yu-Li Shen1, Su-Juan Wang1,2, Khalid Rahman3, Li-Jun Zhang1, Hong Zhang1,4.   

Abstract

All forms of chronic kidney disease (CKD) eventually lead to renal fibrosis irrespective of its origin. It is generally characterized by an excessive accumulation and deposition of extracellular matrix (ECM) and to date, no ideal treatment has been established. Bian-Zheng-Lun-Zhi (syndrome differentiation and treatment), a classic feature of traditional Chinese Medicine (TCM), is a unique method used to diagnose and treat the pathology of a disease. Zheng (syndrome) is used to demonstrate the nature of a disease completely in an extensive and specific manner. Chinese herbal formulas are determined according to TCM theory and this review highlights these formulas and suggests a possible mechanism for their use in the treatment of renal fibrosis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bian-Zheng-Lun-Zhi; Chinese herbal formula; chronic kidney disease; extracellular matrix (ECM); renal fibrosis; traditional Chinesezzm321990Medicine (TCM).

Mesh：

Substances：

Year:  2018        PMID： 30156149     DOI： 10.2174/1381612824666180829103355

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN： 1381-6128            Impact factor:   3.116


  7 in total

1.  Safety and Efficacy Evaluation of Traditional Chinese Medicine (Qingre-Lishi-Yishen Formula) Based on Treatment of Regular Glucocorticoid Combined with Cyclophosphamide Pulse in Children Suffered from Moderately Severe Henoch-Schonlein Purpura Nephritis with Nephrotic Proteinuria.

Authors:  Lirong Fan; Huimin Yan; Xiaofang Zhen; Xiaoming Wu; Jing Hao; Linyi Hou; Lei Han
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-27       Impact factor: 2.629

2.  Extract of Corallodiscus flabellata attenuates renal fibrosis in SAMP8 mice via the Wnt/β-catenin/RAS signaling pathway.

Authors:  Bing Cao; Mengnan Zeng; Yanpo Si; Beibei Zhang; Yangyang Wang; Ruiqi Xu; Yanjie Huang; Weisheng Feng; Xiaoke Zheng
Journal:  BMC Complement Med Ther       Date:  2022-02-28

3.  Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway.

Authors:  Zhuojing Tan; Yachen Si; Yan Yu; Jiarong Ding; Linxi Huang; Ying Xu; Hongxia Zhang; Yihan Lu; Chao Wang; Bing Yu; Li Yuan
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

4.  Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis.

Authors:  Yunling Xu; Jia Chen; He Wang; Ying Lu
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

5.  Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients.

Authors:  Yan-Zhuan Xiao; Zhi-Zhong Ye; Yuan-Tong Liang; Xin-Peng Chen; Yu-Hsun Wang; Qiang Xu; James Cheng-Chung Wei
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

6.  The efficacy of taking traditional Chinese medicine orally in renal interstitial fibrosis: A protocol for a systematic review and meta-analysis.

Authors:  Guang Yu; Mao Guo; Junju Zou; Xiaotao Zhou; Yuerong Ma
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

7.  Shen Shuai II Recipe Attenuates Renal Interstitial Fibrosis by Improving Hypoxia via the IL-1β/c-Myc Pathway.

Authors:  Liuyi Yang; Meng Wang; Yuan Zhou; Jing Yang; Chaoyang Ye; Chen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-07       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.